LATEST ALERTS
Belgium has set new rules for nicotine-free e-liquids, effectively banning all e-liquids containing CBD – and thereby setting up a possible conflict with EU law
This report provides a detailed overview of the current regulatory framework in place in Russia for hemp, CBD and cannabis, covering all areas of policy
Legislation to create a medical cannabis programme in the US state of Kansas appeared to be on the verge of success many times – but it died again as the 2022 session drew to a close
Cannabis consumption is a growing problem in Bavaria and its planned legalisation in Germany would further burden the country’s health system, Bavarian health minister Klaus Holetschek says
This report offers a comprehensive overview of the current regulatory framework in place in Denmark for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
The French Council of State has definitively ruled that a 2021 government decree banning hemp flowers is illegal and must be annulled. This major decision fully authorises French shops to sell CBD products, including flowers, without any fear of punishment for working outside the law
This report provides a detailed overview of Belgium’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
The German Ministry of Health’s budget has been slashed by €1m in a bid to put pressure on health minister Karl Lauterbach to present a draft law for the legalisation of cannabis
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
This report provides an overview of the applicable framework for the movement of hemp and CBD within the borders of the EU as well as the import and export to and from “third countries”
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region’s nations in 2023
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
A 2021 acquisition deal between two cannabis companies over a lucrative shopfront in Orange County, California, has resulted in both companies filing legal claims against each other
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
